TGFB1 and myeloid sarcoma: It was noted that miR-124 downregulation is able to act toward M2 phenotype differentiation thanks to TNF-α downregulation and an upregulation of TGF-β, arginase-1, and FIZZ1, hence making it an important target to establish an anti-inflammatory M2 phenotype in MS patients [56].